In-depth reporting on the intersection between public policy and important health topics ‒ such as insurance coverage, hospital admissions, opioid abuse, access to care, medical research and the business of health care ‒ that impact nearly every Michigan resident.
Munson Healthcare, northern Michigan’s largest employer, will be limiting services at rural hospitals while boosting them in Traverse City. Officials cite staff shortages and rising patient demand for virtual options.
Days after Detroit Rep. Karen Whitsett cast a surprising ‘no’ vote against a package of abortion bills important to Democrats, abortion rights activists applied more public pressure in a bid to change her stand.
Nearly 148,000 Michiganders have lost their Medicaid coverage in the first two months of a year-long, post-COVID renewal process known as “redetermination.” The reason? Most didn’t file their paperwork.
Banned as a controlled substance and dismissed as a hippy trip for decades, psychedelics are getting a closer look to treat a variety of mental and physical ills. U-M is studying its benefits for pain associated with fibromyalgia.
Access to the drug should increase in coming days after thousands of kits are shipped. Michigan has allowed over-the-counter sales since 2017, but not all pharmacies carried the drug that reverses overdoses.
The end of summer signals a new season — one of respiratory diseases. As cases and hospitalizations tick upward, here’s a short, smart update on new variants, new vaccines and the latest advice to stay safe.
The vast majority lost coverage because they had not filled out and returned state forms required to maintain enrollment, as many advocates for vulnerable populations had feared. Many more are likely to be kicked off over the next year.
Deeply conservative political leaders in Ottawa County ratcheted up attacks on the local public health office, ordering steep budget cuts. Ottawa’s embattled health officer is standing firm in a fight that is drawing national attention.
Up to 10,000 older Americans die per year from the RSV virus, which made the approval of the first vaccine a breakthrough. But a new U-M survey shows many either don’t know or don’t care about the vaccine.